Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.33 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.33 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.32 |
| ▸ | ABL1 | P00519 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79201 | 0.97 | MAOA (0.47) | MAOADRD2DRD4DRD3KAT8 | |
| SCHEMBL27951539 | 0.94 | MAOA (0.45) | MAOADRD2DRD4DRD3KAT8 | |
| SCHEMBL28215975 | 0.94 | MAOA (0.45) | MAOADRD2DRD4DRD3KAT8 | |
| Bromide SCHEMBL29027395 | 0.94 | MAOA (0.45) | MAOADRD2DRD4DRD3KAT8 | |
| Fluoride SCHEMBL27944277 | 0.94 | MAOA (0.45) | MAOADRD2DRD4DRD3KAT8 | |
| SCHEMBL30532125 | 0.94 | MAOA (0.45) | MAOADRD2DRD4DRD3KAT8 | |
| Benzene SCHEMBL28241649 | 0.94 | MAOA (0.45) | MAOADRD2DRD4DRD3KAT8 | |
| Bromide SCHEMBL29027396 | 0.94 | MAOA (0.45) | MAOADRD2DRD4DRD3KAT8 | |
| Fluoride SCHEMBL29179319 | 0.92 | MAOA (0.44) | MAOADRD2DRD4DRD3KAT8 | |
| Fluoride Ion SCHEMBL31521528 | 0.92 | MAOA (0.44) | MAOADRD2DRD4DRD3KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9580531-B2 | Poly(ethylene-aliphatic diene) copolymer and preparation method thereof | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2017-02-28 | — | — | US | disclosed |
| US-20150119532-A1 | POLY(ETHYLENE-ALIPHATIC DIENE) COPOLYMER AND PREPARATION METHOD THEREOF | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-04-30 | — | — | US | disclosed |
| US-6861559-B2 | Iminoamines and preparation thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-03-01 | — | — | US | disclosed |
| US-20040110983-A1 | Imminoamines and preparation thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110983-A1 | Imminoamines and preparation thereof | INMT, PNMT, HNMT | MAOA 68/4885DRD2 506/4885DRD4 564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.